Submissions

Online Submissions

Already have a Username/Password for Kazan medical journal?
Go to Login

Need a Username/Password?
Go to Registration

Registration and login are required for submitting items online, and for checking the status of current submissions.

 

Author Guidelines

Preparing the manuscript, authors are kindly requested to adhere to the following regulations based on the “Uniform Requirements for Manuscripts Submitted to Biomedical Journals”, developed by the International Committee of Medical Journal Editors.

The Kazan Medical Journal accepts for publication original articles and reviews in all fields of basic and clinical medicine that have not been published previously or accepted for publication in other printed or electronic media. Manuscripts may be submitted in Russian or English language. All manuscripts submitted to the journal and compliant with these guidelines are subject to peer review.

1. General statements

Submission of the manuscript and correspondence with the editors is carried out through the journal website (https://kazanmedjournal.ru/kazanmedj/author/submit). To submit the manuscript, the author of the correspondence must register at https://kazanmedjournal.ru/kazanmedj/user/register. After registration, the author has the opportunity to track the editorial status of the article, to correspond with the editors, to download the revised version of the article and the accompanying files necessary for publication through the journal website.

By submitting a manuscript to the Kazan Medical Journal, the author guarantees that:

  • the submitted manuscript has not been published previously and at the moment of submission to the Kazan Medical Journal it is not being considered for publication elsewhere
  • the submitted manuscript presents the results of the authors' original research: if data obtained and published by other authors are presented the reference list must contain bibliographic information about those authors' research, and there must be a reference citation in the text
  • the author's employer has consented to publish the data presented, or that the author can confirm this consent on request
  • in case of research on novel medications and treatment methods or invasive diagnostic procedures involving human subjects or animals, Ethics Committee approval is provided
  • the author permits the manuscript and his/her personal information to be published on the website of the Kazan Medical Journal (www.kazanmedjournal.ru), to be used in distribution and made available to the public, in processing and ordering as well as inclusion in databases and information systems
  • all co-authors have seen have seen the final version of the paper and agree to its publication
  • the author agrees with the requirements of the journal, and that the submitted manuscript fully complies with them.

2. Submission fee

Publisher of the "Kazan Medical Journal" requires single Article Processing Charge (APC) per submitted manuscript to defray its editorial and production costs. Charge rate is fixed - 1000 USD (one thousand).

Payment is processed after Step 7 — Confirming the Submission — of the manuscript submission process when the author downloads the paper. Without payment transaction the manuscript will be not sent to the editorial team for peer-reviewing.

The editorial board reserves the right to offer discounts upon an author’s written request.
Articles submitted by postgraduate and postdoctoral students of Russian educational institutions are published free of charge; supporting documents must be provided.

Page charges for advertising articles is 1800 rubles per typeset page.

3. Preparation of manuscripts

All text materials should be prepared in electronic form in MS Word format. When typing and designing the manuscript, it is necessary to use the standard TrueType Fonts (TTF), preferably Times New Roman, should be used with 12pt font size. The space between the lines should be double-spaced. Bold, italic and underlined styles, as well as complex text formatting should not be used unless necessary. The paper should be written in A4 size with margins of 2.5 cm on left, top and bottom sides and 1.5 cm on right side. The pages of the manuscript should be numbered (including the title page and pages with tables and figures).

4. Manuscript structure of the original article

It is strongly recommended to prepare manuscripts in accordance with international standards. You can find detailed guidelines for manuscript preparation for all the article types and all the research types on https://www.equator-network.org/

4.1. The manuscript should contain the following elements in such order:

  • Title page
  • Abstract page
  • Main text
  • References
  • Authors information
  • Tables (if any)
  • Figures (if any)

4.2. All terminology and definitions must be scientifically reliable, their spelling (both Russian and Latin) must comply with the "Encyclopedic Dictionary of Medical Terms".

 

4.3. Title page

The title page should contain the following elements:

  • Title of the article, briefly and accurately capturing its idea; not exceeding 200 characters including spaces. Abbreviations are unacceptable in the title
  • Family name, given name and patronymic (in full) of all authors and place of work of each of them (organization, institution, company, etc.) with the address.
  • The number of authors in original articles and reviews should not be more than five, and in clinical cases - more than three.
  • Complete contact details (mailing address, work phone numbers with area code, mobile phone number, fax and e-mail) for the corresponding author

 

4.4. Abstract page

4.4.1. In the abstract, the author must reflect the main materials of the work in a concise, comprehensible form. The abstract should contain the following five structural elements:

  • Background (research significance) – one or two sentences
  • Aim — one phrase describing the main aim of the study
  • Methods — briefly describe the study groups (number of participants, age, sex), what, how and for how long was studied, what medical intervention (medicine, instrument, method, etc.) was and how it was assessed, what statistical methods were used. (it is not enough to refer only to the used statistical package).
  • Results — salient results, what happened as a result of the study, what indicators and how much changed as a result of medical intervention, comparison of study groups, reliability of changes
  • Conclusion — one phrase corresponding to the aim of the study

4.4.2. In the abstract, it is unacceptable to use abbreviations, brand (trade) names of medicines, medicine, or equipment manufacturers. The length restriction for the abstract is 200-250 words. Keywords should not exceed 5-7 words or short phrases reflecting the essence of the work.

 

4.5. Main body of the article

4.5.1. The main body should be simple and clear, without a long historical introduction, unreasonable repetitions, neologisms and scientific jargon. Generic names should be used when referring to medications; in order to clarify the name of the medication you can use website www.grls.rosminzdrav.ru. Try to avoid a large number of abbreviations in the text. All abbreviations should be preceded by the full name of the original term with the abbreviation in brackets, e.g. "Magnetic Resonance Imaging (MRI)". In general, the text of the article should not contain more than 5-7 abbreviations. Abbreviations met in the text only once or twice are unnecessary. If the article contains more than 7 abbreviations, or they are often encountered, after the abstract, before the main text, you should include the fragment "Accepted abbreviations" and describe all the abbreviations used.

4.5.2. Authors are encouraged to keep the presentation concise, and the results obtained by authors should be clearly differentiated from relevant data in the literature and their interpretations.

4.5.3. The following order is recommended:

  1. Introduction and background/research significance;
  2. Materials and Methods
  3. Results
  4. Discussion
  5. Conclusion
  6. Author contribution statement
  7. The funding source (if necessary)
  8. Conflict of interest
  9. Gratitudes (if necessary)
  10. Reference List
  11. Authors information
  12. Tables
  13. Figures


4.5.4. The title, aim and conclusions of the article should correspond to each other. Conclusions must contain relevant evidence from the data obtained in the work.

4.5.5. In the Introduction it is necessary to describe the problem addressed briefly and the rationale for the investigation, and to state an objective and to justify novelty, the need for the research or observation. Only studies that are directly relevant to the topic should be cited, excluding data and conclusions presented in the article itself.

4.5.6. Describing Materials and Methods of research detailed information should be given about:

  1. the type of study: literature review, experimental, descriptive, analytic (case-control or cohort), or cross-sectional study (single point in time), case report, etc. For randomised trials, a randomization method must be specified. A study protocol should be set out as clearly as possible
  2. the time of the study, its duration (the study years, participating centres)
  3. the method of selecting patients or experimental animals for observation and experiments (including those for control groups), their age, sex and other relevant characteristics
  4. the methods, apparatus (with its manufacturing company and country or city) and all procedures in sufficient detail to allow other investigators to reproduce the results. The quantitative and qualitative characteristics of patients (examined) are given.
  5. cite references to established methods. Identify precisely all drugs and chemicals used, their dosage and administration routes. The trade name of a drug and a manufacturer can be identified in this section in brackets after a generic name of the drug. But it cannot be repeated over and over again throughout the article — this is an advertisement! 
  6. the statistical methods: all statistical criteria used should be mentioned (e.g. Student’s t-test for independent samples, Pearson correlation coefficient), statistical abbreviations should be expanded, e.g. Me (median), etc. It is insufficient to refer only to the used statistical software. The specified statistical processing methods should make it possible to solve the tasks set in the work (to determine the dependencies, show the relationships and their degree, etc.)
  7. the compliance of procedures presented by authors with ethical principles with the name of Ethics Committee that approved the research (when studying treatment methods, invasive diagnostic procedures involving human subjects or animals, protocol numbers and dates).


4.5.7. All clinical trials should be conducted in accordance with the ethical principles of Good Clinical Practice and comply with the requirements of Federal Law No. 61 “On the Circulation of Medicines” (2010), as well as other applicable laws of the Russian Federation: Decree by the Ministry of Health of Russia as of 04.01.2016 №200n "On approval of the rules of good clinical practice", National Standard of the Russian Federation GOST R 52379-2005 "Good Clinical Practice", Federal Law № 323-FZ as of 21.11.2011 "On public health protection in the Russian Federation" and other legal acts that are in force.

4.5.8. All procedures that are not related to providing the standard medical care for the patient's condition are the subject of research and should be carefully justified. Participants in the study must be familiar with the aims and main purpose of the study, with all the diagnostic procedures, treatments and rehabilitation plans that are included in the study (laboratory, functional, radiation and other diagnostic methods, medical appointments, and manipulations not provided in the standard treatment), after which the patient must sign Voluntary Informed Consent to participate (Voluntary Informed Consent to participate in the study and the provision of  routine medical practice are not one and the same!). If the research procedure includes radiation, then it is advisable to describe the procedures and the exposure dose in the "Material and Methods" section.

4.5.9. Confidential information about patients; photographs, names, medical document numbers and other sources by which the patient's identity can be identified; must not be included in the article.

4.5.10. Results of the research should be presented in the text, tables and figures following a logical sequence and avoiding repeating in the text information presented in tables or figures, only important observations should be emphasized or summarized.

4.5.10.1. All Tables and Figures must be referred to in the main body of the text in the appropriate place.

4.5.10.2. The name of the table must reflect its content; abbreviations are not allowed in the name of the tables.

4.5.10.3. In the sub-tabular note, explanations of all abbreviations used in the table should be given, helping to read the table, including the units of measurement of the received data.

4.5.10.4. Bulky constructions should be avoided, it should be clear what is being compared to what and where the calculated data comes from.

4.5.10.5. Measurement values must be in accordance with the International System of Units (SI). If the authors use relative values, then absolute values must be presented.

4.5.11. The editors have the right to request from the authors the primary material under which the article was written.

4.5.12. Statistical significance of obtained results should be reported. When presenting the results (in part) standard error and confidence interval are required. Reporting the results only as arithmetic mean or median is not enough! The level of significance is recommended to be reported rounded to the third decimal place: e.g., p=0.023 instead of p<0.05. All statistical data submitted for publication must comply with the "Uniform Requirements for Manuscripts Submitted to Biomedical Journals". Mathematical formulas should be constructed using the standard tools of MS Word, scrutinized and placed in the text. Units of measure should be given in SI units, temperature in degrees Celsius, blood pressure in mmHg.

4.5.13. In the Discussion section novel and important aspects of the study, possibilities for the implementation of the obtained results also in further studies, as well as their limitations should be emphasized. Results of the study should be critically compared with other studies in this field. This part should not duplicate or replace the "introduction" section, but should have the task of explaining the data obtained and highlighting their novelty, confirming its assumptions based on already known facts obtained by other authors.

4.5.14. An explanation by authors of the results obtained is encouraged.

4.5.15. It is acceptable to combine the last two sections into one — "Results and Discussion".

4.5.16. The Conclusion should be linked with the objectives of the study. Try to avoid unfounded statements that are not supported by the facts.

 

4.6. Author contributions

4.6.1. Each author should have their role listed in the author contribution section. Use verbless expressions.

Example:
A.B.V. and V.V.I. - conducting research; N.A.O. - collection and analysis of results; R.P.S. - work manager.

 

4.7. The funding source

4.7.1. The source of funding for the study should be indicated.

Examples.
1) The study was carried out with the financial support of the state task "Molecular genetic studies of prostate pathology", registration number 120-02231007-2 of 2018.
2) The study was not sponsored.

 

4.8. Conflict of interest

4.8.1. All authors must disclose (declare in the relevant section) any financial or other actual or potential conflict of interest that may be perceived as influencing the results or conclusions presented in the manuscript.

4.8.2. Sample disclosure statements.

1)  The authors report no potential conflict of interest related to the manuscript.
2)  The authors report a conflict of interest related to, e.g.:

  • receiving grant money to conduct research or for writing a manuscript
  • any relationship (employment, consultancies, stock ownership, honoraria, paid expert testimony) with organizations with direct interest in the subject of the study or review
  • patent applications or registrations of the research results (copyright, etc.)
  • financial support for the conduct of any step of the research or preparation of the article (including grants and other financial support)

4.8.3. In the presence of sponsorship, authors should indicate the role of the sponsor of the study (participation in determining the design of the study, collecting material, analyzing and interpreting data, writing the text of the article, etc.). 

4.8.4. Information about conflict of interest reported by the authors of the manuscript is not provided to the peer reviewers and is available only to the editorial board when making a decision on publication. Information about conflict of interest is published in the full text article.

 

4.9. Authors can express gratitude (Acknowledgements) to natural persons or legal entities who assisted the authors of the manuscript at different stages of its preparation and can identify who provided financial support for the research.

4.9.1. It is recommended that in the acknowledgement, you include information of people who provided technical, organizational or general support, or who facilitated the study, but did not otherwise meet authorship criteria.

If authors have used editing agencies, they should thank them for their ethical participation in the same section. See clause 9 of the Declaration of Sarajevo https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5209927/pdf/CroatMedJ_57_0527.pdf

 

4.10. Reference list

Reference list should be placed at the end of the main body of the manuscript

List of references should be organized according to the guidelines by U.S. National Information Standards Organization NISO Z39.29-2005 [R2010]) in AMA slyle (Journal of American Medical Association style, http://www.amamanualofstyle.com). For detailed instructions on bibliographic formatting, see «References list guidelines». The following are the principle points you should be aware of while preparing your manuscript for submission:

    • References should be numbered in the order in which they are cited.
    • Number of cited works: 12-15 are allowed in original articles, up to 100-120 in review articles, but not less than 40 sources..
    • Within the body of the text references should be provided in Arabic numerals enclosed in square brackets.
    • A complete list of all authors should be presented in every bibliographical entry. Do not shorten titles of your citations. Shortened journal titles should correspond to the MedLine catalogue. If the journal is not indexed by MedLine, please provide its full title.

 

4.11. Authors information

4.11.1. In the following order, in Russian and English, you should indicate:

  • full name;
  • academic degree;
  • academic title;
  • position;
  • affiliation;
  • other ranks and titles;
  • email address;
  • ORCID identifier.

 

4.12. Tables should be illustrative and compact and contain statistically processed data.

4.12.1. The total number of tables should not exceed three. If the authors prove the need for more tables, after approval by the editorial board it is liable to an additional charge.

4.12.2. In order to create tables, standard tools of MS Word or Excel should be used. Each table should be typed with double spacing on a separate page and numbered consecutively in the order in which they are first mentioned in the text.

4.12.3. Each table should have a short title, and each column should have a short header (you can use abbreviations that must be defined in a footnote).

4.12.4. All explanations should be placed in a footnote, but not in the title of the table.

4.12.5. Authors should specify which statistical parameters are used for representing the variability of the data, e.g. standard deviation and standard error of the mean.

4.12.6. As an alternative to tables with a lot of data, graphs are recommended.

4.12.7. The title of the table, its data and footnotes should be sufficient to understand the information presented in the table without reading the text of the article.

 

4.13. Figures and charts.

4.13.1. Figures presented in the text and separate files should meet the following requirements:

  • file format * .tif or * .jpg;
  • width 70 to 140 mm, height not exceeding 200 mm.
  • minimum resolution of 300 dpi (pixels per inch);
  • scanned images should be cropped, and dust and scratches should be removed.

4.13.1.1. The total number of figures should not exceed 3-5. If the authors prove the need for more figures, after approval by the editorial board; it is liable to an additional charge.

4.13.1.2. Photos of potentially recognizable people should be presented with the use of de-identification methods. On roentgenograms, tomograms, the names of patients should not be visible.

4.13.1.3. All figures should be original. Publication of unoriginal images is possible only after receiving copyright permission.

4.13.1.4. Each figure should be accompanied by a short legend, which along with the figure content should be sufficient to understand the information presented in the figure without reading the text of the article.

4.13.2. Charts and graphs should be editable.

4.13.2.1. In histograms alternating solid color (black, white, grey) and pattern (hatching, diamonds, etc.) is recommended.  In charts, the use of clearly distinguishable markers and dashed or dotted lines is recommended.

4.13.2.2. All digital data and footnotes should be well distinguishable.

4.13.2.3. Each figure should be accompanied by a short legend, which along with figure content should be sufficient to understand the information presented in the figure without reading the text of the article.

4.13.2.4. Charts and graphs should be presented both in the text and in separate files with the native file format.

5. Structure features of other types of manuscripts

5.1. In general, authors should follow the rules given above during the preparation of manuscripts taking into account the following features.

5.2. Abstracts of review articles may be presented without dividing them into sections.

5.3. Literature reviews should indicate where (in what sources, databases) the material was collected; if digital material is used, a reference to statistical sources - open or departmental materials (in particular, when indicating the state of the problem in terms of morbidity, prevalence of pathology, mortality) or memorandum records is mandatory.

5.4. The use of basic publications is allowed, but the overwhelming majority of sources should be publications from recent 3-5 years.

5.5. It is desirable that the reviews comply with international recommendations for systematic literature search methods and standards.

5.6. The keywords of review articles should include the word “review”.

5.7. Other types of publications (letters to the editor, reviews of monographs, conference information, jubilees, etc.) may be submitted without abstracts. Keywords should be given in all cases.

Abstract of review articles should contain information about the methods of literature search in the databases Scopus, Web of Science, MedLine, The Cochrane Library, EMBASE, Global Health, CyberLeninka, RSCI and others.

 

Submission Preparation Checklist

As part of the submission process, authors are required to check off their submission's compliance with each of the following items, and submissions that do not adhere to these guidelines may be returned to the authors.

  • Submitted manuscript has not been published previously and at the moment of submission to “Kazan Medical Journal”is not being considered for publication elsewhere;

  • Submitted manuscript presents the results of authors' original research; if the data received and published by other authors are presented, the reference list contain bibliographic data of these authors' research and there is a reference citation in text;

  • The author's employer has consented to publish presented data or the author can confirm it on request;

  • In case of the research of novel medications and treatment methods or invasive diagnostic procedures involving human subjects or animals, Ethics Committee approval is provided;

  • All co-authors have seen have seen the final version of the paper and agree to publication.

 

Copyright Notice

Authors who publish with this journal agree to the following terms:

  1. Authors retain copyright and grant the journal exclusive license to first publication.
  2. Authors are able to distribute the manuscript and/or the article in accordance with Self-Archiving policy of the journal (see details).
  3. The manuscript can be accepted for publication only by decision of the Editor-in-Chief and the Editorial board of the journal in accordance with the Manuscript stelection policy of the journal (see details).
  4. Published Article will be distributed in print and electronic version an will be available under subscription with Delayed Open Access or in Immediate Open Access under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0). The access model depends on the publisher's decision or is determined by a separate Open Access publishing agreement with the authors.

An exclusive license for publication granted by authors allows the publisher to use the article in the following ways:

  • Reproduction of the Article or its sections or parts, as well as the metadata of the Article in any languages, in any material form, including on paper and electronic media, as a separate work in the journal and/or databases (local or in the Internet) of the publisher and/or other persons, at the discretion of the publisher;
  • Distribution of the Article or its sections or parts, as well as the metadata of the Article in any languages, on any medium as part of the journal and/or databases of the publisher or other persons, at the discretion of the publisher, or as an independent work around the world whether on Open-Access terms or for a fee without remuneration to the Author;
  • Making the Article or any of its sections or parts, as well as the Article’s metadata in any languages, publicly available in such a way that any person can access the Article from any place, including via the Internet, and at any time of their own choosing;
  • Granting permission/s for the use of the Article or its sections or parts, as well as its metadata in any languages, to third parties with notice to the Author made by posting relevant information on the journal’s website, without paying remuneration to the Author;
  • Processing the Article (i.e., editing, correcting, annotating, tagging, translating to any languages, typesetting) and using the revised (translated) Article in the aforementioned ways.

Other rights not directly transferred to the publisher under this License Agreement, including patent rights to any process, method etc., described by the Authors in the manuscript, as well as trademark rights, are reserved for the Authors.

All the Copyright statements for authors are present in the standart Publishing Agreement (Public Offer) to Publish an Article in an Academic Periodical 'Kazan medical journal'.

- DOWNLOAD the print-version of the License Agreement.

READ the details online (tap to see in details)

Author’s license agreement (public offer) on the publication of an article in a scholarly journal
“Kazan medical journal”

Eco-Vector, represented by its CEO Evgeniy Schepin and acting on the basis of the Charter (hereinafter referred to as the Publisher), on the one hand, offers an indefinite circle of persons (hereinafter referred to as the Author), and on the other hand, hereinafter jointly referred to as the Parties, to execute this agreement (hereinafter referred to as the Agreement) on the publication of scientific article (hereinafter referred to as the Article) in a scholarly journal “Kazan medical journal” (further-the Journal) in accordance with the conditions stated below.

 

I. General Provisions

  1. This Agreement, in accordance with clause 2 of Article 437 of the Civil Code of the Russian Federation, is a public offer (hereinafter referred to as the Offer) requiring full and unconditional acceptance (Acceptance), which, in accordance with Article 438 of the Civil Code of the Russian Federation, means the sending by the Author of his/her materials by way of uploading the same to the online electronic system designed to accept manuscripts for consideration, and subsequently posted in the corresponding section of the Journal’s website on the Internet information and telecommunications network (hereinafter referred to as the Internet).
  2. In accordance with the current legislation of the Russian Federation regarding the observance of copyright on electronic information resources, all materials found in a website, including submitted and published in electronic journals, may not be reproduced in whole or in part in any form (electronic or printed) without the prior written permission of the Publisher. Prior permission can be given by publishing an article in the open access with Creative Commons license. The journal requires license users to reference the original source, i.e., the publication, if the Author permits use of the public materials in the context of other documents.

 

II. Terms used in the Agreement

  1. “Author” refers to an individual (or individuals) whose creative work has led to the creation of the manuscript of a scientific Article, or to a representative of these persons.
  2. “Manuscript” is the result of intellectual activity in the form of a scientific work containing text, graphic and numerical data, audiovisual information, program code and other elements submitted by the Author for publication in the Journal; it is also the mean “a draft of an Article submitted by the Author to be published in the Journal”.
  3. “Offer” is the current agreement (an offer to the author for the publication of an Article in the Journal).
  4. “Publication” is the process of placement of an Article in the Journal.
  5. “Article” is the manuscript that has been published in the Journal (after successful selection, editing, type-setting, copyediting, proofreading, translation).
  6. “Acceptance of the offer” refers to the full and unconditional acceptance of the offer on the terms specified in paragraph 3 of this agreement (the Author accepts offer by submitting a Manuscript to the Publisher via the online electronic submission system on the Journal’s Internet website).
  7. “Journal” is a scientific peer-reviewed periodical registered as a mass media entity in the Roskomnadzor register of the Russian Federation and ISSN-center.
  8. “Submission” is an electronic appeal of the Author to the Publisher for the publication of an Article in the Journal by uploading the manuscript and accompanying materials to the online electronic submission system on the Journal’s Internet website).
  9. “Publisher” refers to Eco-Vector, which is the Publisher of the journal.
  10. Article metadata includes the information that are intended for inclusion in International Scientific Databases and search engines, namely the following:
    • title of the Article;
    • information about each of the Authors (surname and first name; patronymic; place of work with the postal address indicated, contact information (e-mail));
    • abstract;
    • keywords;
    • thematic rubricator: UDC (Universal Decimal Classification) or other library and bibliographic classification and subject indexes;
    • list of references.
  11. “Editorial board” is the creative team that prepares the journal for publication.
  12. “Parties” refers to the Author and the Publisher.
  13. “Author Guidelines” are the requirements for Articles published in the Journal, posted in the “For authors” section of the Journal’s Internet website.

 

III. Subject of the Agreement (Offer)

  1. Under this agreement, the Author grants the Publisher, free of charge for the entire period of validity in accordance with the legislation of the Russian Federation, an exclusive license to use the Article created by the former for publication in the Journal, as well as the rights to use the article in the following ways:
    • Reproduction of the Article or its sections or parts, as well as the metadata of the Article in any languages, in any material form, including on paper and electronic media, as a separate work in Journals and/or databases (local or in the Internet) of the Publisher and/or other persons, at the discretion of the Publisher;
    • Distribution of the Article or its sections or parts, as well as the metadata of the Article in any languages, on any medium as part of the Journal and/or databases of the Publisher or other persons, at the discretion of the Publisher, or as an independent work around the world whether on Open-Access terms or for a fee without remuneration to the Author;
    • Making the Article or any of its sections or parts, as well as the Article’s metadata in any languages, publicly available in such a way that any person can access the Article from any place, including via the Internet, and at any time of their own choosing;
    • Granting permission/s for the use of the Article or its sections or parts, as well as its metadata in any languages, to third parties with notice to the Author made by posting relevant information on the Journal’s website, without paying remuneration to the Author;
    • Processing the Article (i.e., editing, correcting, annotating, tagging, translating to any languages, typesetting) and using the revised (translated) Article in the aforementioned ways.
  2. Other rights not directly transferred to the Publisher under this Agreement, including patent rights to any process, method etc., described by the Author in the Article, as well as trademark rights, are reserved for the Author.
  3. The territory where the rights to the Article are allowed to be used is the whole world.
  4. The validity of this Agreement commences only if the manuscript of the Article is accepted for publication in the Journal and only from the moment of sending a notification of acceptance of the Article for publication to the Author from the official e-mail of the Journal.
  5. The rights are granted by the Author to the Publisher free of charge; the publication of the Article in the Journal does not entail any financial deductions to the Author.
  6. If the Publisher decides to reject the Submission or refuse to publish the Article in the Journal (i.e., retraction of the published Article), this Agreement becomes invalid. The decision to refuse publication will be sent to the Author at the e-mail address specified in the Submission.

 

IV. Rights and Duties of the Parties

  1. The Author guarantees that:
    • s/he holds the copyright the exclusive rights to the materials submitted to the Publisher as part of the manuscript of the Article;
    • the rights granted to the Publisher under this agreement have not been previously transferred and will not be transferred to third parties in the future during the duration of the Agreement;
    • the manuscript contains all references to the cited authors and/or publications (materials) provided for under the current copyright legislation;
    • the Author has obtained all the necessary permissions for all information and other materials s/he holds no copyright to and that are used in the manuscript of the Article;
    • the Article manuscript contains only materials permitted to be published in the open press in accordance with the current legislative acts of the Russian Federation, and its publication and distribution will not lead to the disclosure of secret (confidential) information (including state secrets);
    • the Author has informed co-authors about the terms of this Agreement and has received their consent to execute this Agreement under the terms provided for in the Agreement.
  2. The Author carries certain obligations under the terms of the Agreement:
    • s/he should prepare and submit the manuscript of the Article in accordance with the Author Guidelines posted on the Journal’s website;
    • the Author should not use an electronic copy of the Article for commercial purposes and in other journal publications without the consent of the Publisher;
  3. in the process of preparing a manuscript for publication, the Author is obligated to undertake the following:
    • make corrections to the text of the manuscript that have been marked by the peer-reviewers and accepted by the editorial board, and/or as necessary, upon the request of the Publisher and the editorial board, finalize the manuscript of the Article;
    • revising and proofreading the manuscript of the Article in accordance with the editorial recommendations;
    • suggest only the minimum of corrections to the type-setted (layout) Article.
  4. The Author has the following rights and duties:
    • Use preprint or prior-to publication versions of an unpublished Article in the form and content accepted by the Publisher for publication in the Journal. Such prior-to-publish versions can be placed as electronic files on the personal websites of the Author (co-authors) or on the protected external websites of the employers of the Author; however, the Author cannot use the unpublished version(s) for commercial sale or for systematic external distribution by a third party (i.e., post on social media). The author or co-authors must, in turn, carry out certain duties, namely:
      • include the following warning in the prior-to-publish version: “This is prior-to-publish version of the article accepted for publication in (Journal’s name), © Eco-Vector (year)”;
      • provide the corresponding electronic link to the Publisher’s website at https://journals.eco-vector.com/ and/or via the DOI.
    • Copy or transfer a copy of the published Article in whole or in part to colleagues free of charge for their personal or professional use, for the promotion of academic or scientific research, or for informational purposes of the Author’s employer.
    • Use materials from a published Article in a book written by one of the co-authors.
    • Use figures, tables and text excerpts from the Article for his or her (or co-authors’) own training purposes, or to include them in other published works in printed or electronic format by a third party, or to submit them in electronic format on an internal computer network, or on the public website of the Author (co-authors) or his/her employer.
    • Include the Article in educational collections for use in the classroom, either for free distribution to the Author’s (co-authors’) students or in electronic format on a local server for access by students as part of the training course, as well as for internal training programs at the institution of the Author’s employer.
  5. The Publisher, for its part, is obliged to:
    • publish the Author’s article in the Journal in printed and electronic form in accordance with the terms of this Agreement;
    • if necessary, as so decided by the Journal’s editorial board, provide the Author with the proofreading of the manuscript and make a reasonable editing;
    • provide to the Author the unlimited access to the final electronic version of the published Article (Version of Record) through the online electronic submission system on the Journal’s Internet website;
    • comply with the Author’s rights as provided for by the current legislation, as well as protect them and take all necessary measures to prevent copyright infringement by third parties.
  6. The Publisher has a right to:
    • conduct an expert evaluation of the manuscript (peer-reviewing and editorial evaluation) and invite the Author to make the necessary changes (revisions) to the manuscript;
    • provide editing, copyediting, type-setting, proofreading, tagging, indexation and translation of the Article’s manuscript without altering the main content;
    • in any subsequent authorized use by the Author (and/or other persons) of the Journal and/or Article (including any separate part or fragment thereof), require that a link to the Journal, Publisher, Author or other copyright holders, the title of the Article, the Journal’s volume/issue, and the year of publication be specified in the Journal;
    • post preliminary and/or advertising information about the upcoming publication of the Article in the media and other information sources;
    • make changes to the offer in accordance with the procedure established by the offer.
  7. The editorial board of the Journal, headed by the editor-in-chief, has the exclusive rights to select and/or reject materials sent to the Journal editorial office for publications purposes. The manuscript sent by the Author to the Journal editorial office is not subject to return. The editorial board of the Journal does not enter into correspondence about rejection of submissions.
  8. In all cases not stipulated and not provided for in this agreement, the parties are obliged to be guided by the relevant current laws of the Russian Federation.

 

V. Acceptance of the Offer and Execution of the Agreement. Terms of the Agreement

  1. The Author accepts the Offer by submitting the manuscript on the Article to the Publisher through the electronic manuscript submission system on the Journal's Internet website.
  2. Acceptance of the offer by the author creates an Agreement in writing (Articles 438 and 1286.1 of the Civil Code of the Russian Federation) on the terms of the offer.
  3. This Agreement is valid for the duration of the exclusive rights to the Article.
  4. When transferring (alienating) the exclusive right to the Article by the Author to a third party, this Agreement does not terminate.

 

VI. Procedure for changing and terminating the Agreement

  1. The Publisher has the right to unilaterally change the terms of this Agreement, in advance, at least 10 (ten) calendar days before the entry into force of the intended relevant changes, but with notice to the Author through the Journal’s website or by e-mail to the Author’s e-mail address specified in the Author’s Submission. The changes will take effect from the date specified in the relevant notification.
  2. If the Author rejects the changes to the terms of this Agreement, s/he has the right to notify the Publisher by sending a written notification through the online manuscripts submission system, making sure that the same is sent to the official e-mail address of the editorial office.
  3. This Agreement may be terminated prematurely, either by agreement of the parties at any time, or on other grounds provided for in this Agreement.
  4. The Author has the right to unilaterally withdraw from the execution of this Agreement by sending the Publisher a corresponding notification in writing at least 60 (sixty) calendar days in advance before the expected date of publication of the Article in the Journal.
  5. Termination of the Agreement for any reason does not release the parties from liability for any violation of the terms of the Agreement that occurred during the validity period.

 

VII. Responsibility

  1. The parties are responsible for non-fulfillment or improper fulfillment of their obligations under the Agreement in accordance with the current relevant legislation of the Russian Federation.
  2. All information provided by the Author must be reliable. The Author is expected to provide accurate and complete the information to the Publisher. When using false information received from the Author, the Publisher is not responsible for the negative consequences caused by his actions on the basis of the false information provided.
  3. With regard to the content of the Article, the Author is solely responsible for compliance with the requirements of the laws of the Russian Federation pertaining to advertising, copyright and related rights’ protection, protection of trademarks and service marks, and the protection of consumer rights.
  4. The Publisher does not bear any responsibility under the agreement:
    • for any actions that are a direct or indirect result of Author’s illegal actions;
    • for any loss incurred by the Author, regardless of whether the Publisher could have foreseen the possibility of such losses or not.
  5. The Publisher is released from liability for violation of the terms of the Agreement if such violation is caused by force majeure, including actions of state authorities (including the adoption of legal acts), fire, flood, earthquake, other natural disasters, lack of electricity and/or computer network failures, strikes, civil unrest, riots, etc.

 

VIII. Dispute resolution

  1. Disputes and disagreements will be resolved by the parties through negotiations, and in case of failure to reach an Agreement they will strive to seek resolution in accordance with the current legislation of the Russian Federation.
  2. If there are unresolved disagreements, the parties agree to resolve the disputes in court at the jurisdiction covered by the Publisher’s location in accordance with the current legislation of the Russian Federation.

 

IX. Miscellaneous

  1. All notifications, messages, requests, etc. (with the exception of documents that must be sent as originals in accordance with the laws of the Russian Federation) are considered received by the Author if they were transmitted (sent) by the Publisher through the Journal’s website (including by publication), fax, e-mail based on the address specified in the Submission, and other communication channels. The parties recognize the legal force of notifications, messages, requests, etc., transmitted (sent) by the above methods.
  2. In the event of claims against the Publisher related to the violation of the exclusive copyright and other intellectual property rights of third parties when creating an article or in connection with the execution of this Agreement by the Author, as well as in connection with the use of the Article by the Publisher in accordance with the Agreement, the author undertakes:
    • To immediately take measures to resolve disputes with third parties soon after receiving Publisher’s notification, and if necessary, enter into legal proceedings on the Publisher’s side and take all appropriate actions needed to exclude the Publisher from the list of defendants;
    • To reimburse the publisher for the legal costs incurred and expenses and losses caused by the application of measures to secure the claim and execute a court decision, and the money paid to a third party for the violation of exclusive copyright and other intellectual property rights, as well as other losses incurred by the Publisher in connection with the Author’s non-compliance with the guarantees provided by them under this Agreement.

 

X. Legal address and details of the Publisher

  • Eco-Vector
  • Address: 191186, St. Petersburg, Aptekarsky Pereulok, 3 letter A, room 1N
  • TIN: 7806423692; KPP: 784101001; OGRN: 1099847039907.

 

Privacy Statement

Your contact details and addresses, specified when registering, will be used solely for technical purposes: to contact you or reviewers (editors) when preparing the article for publication. Private data will not be shared with other individuals and organizations. 

Unpublished materials disclosed in a submitted manuscript must not be used in a reviewer’s own research without the express written consent of the author. Privileged information or ideas obtained through peer review must be kept confidential and not used for personal advantage.

Reviewers should not consider manuscripts in which they have conflicts of interest resulting from competitive, collaborative, or other relationships or connections with any of the authors, companies, or institutions connected to the papers.

 

Author Fees

General information on paid services for authors

Along with many other journals in the wider community, around 25 of the journals published by Eco-Vector levy Article Submission Charge (ASC).

'Kazan medical journal' charges ASC, and this is clearly flagged in the journal's guide for authors and during the submission process (on the step 1 and step 7). As described below, all monies derived from ASC are used to support the journal and article selection quality.

'Kazan medical journal' do not levy any mandatory additional fees from authors (NO Article Processing Charge, NO Article Publication Charge).

Eco-Vector Publishing house offers authors a number of additional paid services DOES NOT AFFECT the peer-review results and the editorial board decisions:

  • FastTrack (emergency peer-review of the manuscript);
  • Immediate Open Access*;
  • Full-text translation* from English and other languages.

*available only for authors whose manuscript has been accepted for publication by the editorial board, and only after the appropriate notification from the editorial team.


 

Article Submission Сharge

Price: 250.00 (USD)

OBLIGATORY PAYMENT

Publisher of the "Kazan Medical Journal" requires single Article Submission Сharge (ASC) per submitted manuscript to defray its editorial consideration costs. 

ACS is for the manuscript consideration process that includes:

  • initial manuscript consideration by editors for compliance with Guidelines for Authors and Editorial Policies;
  • checking for plagiarism;
  • manuscript processing for double-blind peer-review, administration of authors-to-reviewers-to-authors communication;
  • presentation of an article and the peer-review results for the Editorial board;
  • communication with authors on all the Editorial board's decisions.

Payment is processed after Step 7 — Confirming the Submission — of the manuscript submission process when the author downloads the paper. Without payment the manuscript will not be considered by the editors.

Payment can be made by:

  • Online processing. This way is available for the author when submitting a manuscript directly via the web-page of the journal.
  • Bank Wire Transfer. Transaction should be made to the bank details of "Eco-Vector". To receive the bank transfere details, please, contact the Publisher (see. here).

In confirmation of successful sending the manuscript to the editor, you will receive an official notification from to your e-mail.

ATTENTION! ASC does not guarantee the publication of a manuscript in "Kazan medical journal"! The fee is not refundable in the case of refusal to publish after peer-reviewing or failure to review the paper for publication by objective reasons (failure to comply with the authors of author's copyright provisions; negative reviews; author(s) failure to meet a deadline for manuscript corrections; refusal to adopt/correct/update the manuscript in accordance with the requirements of the editorial board; violation of publication ethics guidelines).


Fast-Track:

Price: 1100.00 (USD)

OPTIONAL PAYMENT

The Fast-Track is a review process and editorial workflow to authors seeking a very fast editorial decision and rapid publication at a higher submission fee to compensate the extreme fast referees and editorial work.

For the Fast-Track users:

  • the guaranteed response time (report and decision letter) is 21 days, starting the count from the first business day on which valid payment information has been received from the submitting author;
  • the guaranteed issue for publication (in case of manuscript acceptance) is a nearest upcoming issue of the journal.

If you choose “Fast-Track” for your manuscript the submission fee is US$1100.

Please note, that the “Fast-Track” option does not guarantee a positive review and acceptance of a manuscript itself. It's only brings an extreme fast time scedule for manuscript processing thrue all editorial procedires. Thus, if the manuscript receives negative reviews, and if the editorial board will take the side of reviewers, the manuscript will be rejected. If the reviewers recomend revisions of the manuscript, the final decision on publication will be only after revised manuscript submission and the second round of review.

The Fast-Track option does not exclude the necessary for correct manuscript formatting. Please ensure that the manuscript corresponds to the formatting guidelines for this journal (you can find them on Author Guidelines page).

To activate the Fast-Track option, the submitting author should make payment from his/her personal account on the journal's website after submitting an article. After making the payment and sending the notification to the editor, the authors will receive confirmation by email and within the next 21 days — the results of the article reviewing and the editorial decision.

In opposite to the Fast-Track option authors can use the standart protocol for manuscript selection in our journal (review and editorial workflow). The standart time for review and editorial workflow are described in detail on the PeerReview page. You can also find the statistic info about the editorial workflow on the STAT page.


Immediate Open Access:

Price: 950.00 (USD)

OPTIONAL PAYMENT (this will NOT abrogate the Peer-Review decesion-based article selection)

Through optional Immediate Open Access, authors of accepted papers are given the option of paying an open access publication charge to make their paper freely available online immediately via the journal website, meaning that readers will not need a journal subscription to view open access content. If an author does not choose to pay the open access publication charge, their paper will be published in the normal manner, and will not be made freely available online immediately.

Therefore there will be a mixture of non-open access and open access papers within each journal issue. Open access articles will be clearly indicated on the journal's online contents page. In order to view the non-open access content, a current subscription to the journal will be required. Online, print and combined subscription options will continue to be available to institutions. 


Submission fee waivers and discounts

All Eco-Vector's journals which charge an ASC offer a number of waivers for authors with limited means. 

The fee for paid editorial services can be reduced or voided at the request of any authors team.

If the author is a member of the editorial board or a reviewer of 'Kazan Medical Journal', a graduate student, or Ph.D. student, the Eco-Vector Publishing House provides a discount for ASC:

  • 100% for single-author publication;
  • proportionally, depending on the number of authors in the manuscript, but not less than 10%.

To receive a discount, please, select “Request an Exception” on the Step 7 of the Manuscript submission precess and write a message to the editor in the appropriate field. With the filled request the author will be able to complete the manuscript submition process without simultaneously paying online.

Decisions on all the waivers requests are for Editor-in-Chief consideration. If the discount is approved, authors will be informed of the final total cost and further payment instructions.



This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies